$10.73 B
Share price
Change (1 day)
Change (1 year)
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the worldโ€™s smallest heart pump.

Market capitalization of Abiomed (ABMD)

Market cap: $10.73 Billion

As of May 2022 Abiomed has a market cap of $10.73 Billion. This makes Abiomed the world's 1359th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.

Market cap history of Abiomed from 2001 to 2022

Year Market cap Change
2022$10.73 B-34.29%
2021$16.34 B11.54%
2020$14.65 B90.37%
2019$7.69 B-47.45%
2018$14.64 B76.74%
2017$8.28 B69.52%
2016$4.88 B27.59%
2015$3.83 B145.05%
2014$1.56 B47.04%
2013$1.06 B103.49%
2012$0.52 B-26.64%
2011$0.71 B95.82%
2010$0.36 B11.15%
2009$0.32 B-45.53%
2008$0.60 B18.59%
2007$0.50 B34.27%
2006$0.37 B54.86%
2005$0.24 B-28.38%
2004$0.34 B129.47%
2003$0.14 B93.83%
2002$0.07 B-76.87%
2001$0.33 B

End of Day market cap according to different sources

On May 21st, 2022 the market cap of Abiomed was reported to be:

$10.73 Billion
by Nasdaq
$10.73 Billion
by CompaniesMarketCap
$10.73 Billion
by Iex Cloud
$10.72 Billion
by Yahoo Finance

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$56.06 B 422.18%๐Ÿ‡บ๐Ÿ‡ธ USA
$13.47 B 25.49%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.02 B-81.17%๐Ÿ‡บ๐Ÿ‡ธ USA